Future of toxicogenomics and safety signatures: balancing public access to data with proprietary drug discovery

Pharmacogenomics. 2007 May;8(5):425-30. doi: 10.2217/14622416.8.5.425.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Intramural

MeSH terms

  • Access to Information*
  • Animals
  • Biomarkers / analysis
  • Drug Design*
  • Drug-Related Side Effects and Adverse Reactions*
  • Gene Expression / drug effects
  • Humans
  • Oligonucleotide Array Sequence Analysis
  • Toxicogenetics* / methods
  • Toxicogenetics* / standards
  • Toxicogenetics* / trends

Substances

  • Biomarkers